Twin Capital Management Inc. Sells 8,240 Shares of CME Group Inc. $CME

Twin Capital Management Inc. cut its holdings in shares of CME Group Inc. (NASDAQ:CME) by 87.4% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,183 shares of the financial services provider’s stock after selling 8,240 shares during the period. Twin Capital Management Inc.’s holdings in CME Group were worth $320,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Caldwell Trust Co lifted its position in shares of CME Group by 116.3% in the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 50 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new stake in CME Group in the third quarter worth about $27,000. Financial Consulate Inc. bought a new stake in CME Group during the 3rd quarter valued at approximately $28,000. Sagard Holdings Management Inc. purchased a new position in shares of CME Group during the 2nd quarter worth approximately $30,000. Finally, Corundum Trust Company INC bought a new position in shares of CME Group in the 3rd quarter worth approximately $30,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Q4 earnings beat and commentary reinforced the firm’s resilient fee-based franchise — investors reacted to better-than-expected quarterly results and the company hitting a new one-year high after the report. Earnings Call Transcript
• Positive Sentiment: Deutsche Bank raised its price target to $316 and maintained a buy rating, giving fresh analyst support that can help momentum. Deutsche Bank PT Raise
• Positive Sentiment: Morgan Stanley reiterated a Buy rating, highlighting CME’s defensive, fee-based franchise and structural growth drivers. Morgan Stanley Note
• Neutral Sentiment: RBC nudged its target to $302 (sector perform) — a small technical change that largely preserves prior sentiment. RBC PT Adjustment
• Positive Sentiment: Management confirmed the firm is exploring a CME-issued digital token and tokenized cash pilots (including work with Google), a strategic move that could expand 24/7 crypto/product offerings and new non-trading revenue streams. CME Token Exploration
• Negative Sentiment: CME raised initial and maintenance margins for gold and silver futures (e.g., gold margins to 9% from 8%, silver to 18% from 15%) to manage sharp volatility — measures that can damp trading volume and futures activity in the near term. Margin Hikes
• Negative Sentiment: Pelican Bay Capital reported selling CME in Q4, signaling at least some institutional trimming that could weigh on sentiment if others follow. Institutional Selling
• Negative Sentiment: JPMorgan still carries an underweight rating despite updating its target — a reminder there are pockets of skepticism about valuation and upside. JPMorgan Note

CME Group Stock Performance

Shares of CME stock opened at $302.27 on Monday. The company has a market capitalization of $109.00 billion, a price-to-earnings ratio of 27.09, a price-to-earnings-growth ratio of 3.29 and a beta of 0.27. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03. CME Group Inc. has a one year low of $239.70 and a one year high of $302.79. The company’s 50-day moving average is $276.90 and its 200 day moving average is $273.00.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the company earned $2.52 earnings per share. The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. Sell-side analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms recently weighed in on CME. JPMorgan Chase & Co. lifted their price target on CME Group from $262.00 to $266.00 and gave the company an “underweight” rating in a research report on Thursday. Raymond James Financial dropped their target price on shares of CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a report on Wednesday, February 4th. Jefferies Financial Group decreased their price target on shares of CME Group from $304.00 to $302.00 and set a “buy” rating for the company in a research note on Monday, January 12th. Piper Sandler boosted their price objective on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Finally, Royal Bank Of Canada raised their target price on shares of CME Group from $295.00 to $302.00 and gave the company a “sector perform” rating in a research note on Thursday. Nine investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $297.47.

Insider Activity at CME Group

In other CME Group news, Director William R. Shepard purchased 251 shares of the firm’s stock in a transaction dated Tuesday, December 30th. The stock was purchased at an average price of $278.37 per share, for a total transaction of $69,870.87. Following the completion of the purchase, the director directly owned 258,710 shares of the company’s stock, valued at $72,017,102.70. This trade represents a 0.10% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Terrence A. Duffy sold 25,000 shares of the company’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $269.55, for a total value of $6,738,750.00. Following the transaction, the chief executive officer directly owned 65,804 shares in the company, valued at approximately $17,737,468.20. The trade was a 27.53% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.